Clinical Benefit of Adding Oxaliplatin to Standard Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: A Meta-Analysis

BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3323-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Recent Advances in Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Journal of the Anus, Rectum and Colon
2017English

MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

MicroRNA Expression Profile Associated With Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2012English

Gene Expression Profiles of Tumor Regression Grade in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy

Oncology Reports
MedicineCancer ResearchOncology
2012English

Prognostic Significance of Clinical and Pathological Stages on Locally Advanced Rectal Carcinoma After Neoadjuvant Chemoradiotherapy

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2015English

Erratum To: Kinetically Guided Neoadjuvant Chemoradiotherapy Based on 5-Fluorouracil in Patients With Locally Advanced Rectal Cancer

Clinical Pharmacokinetics
Pharmacology
2015English

Effect of Adding mFOLFOX6 After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Multicentre, Phase 2 Trial

The Lancet Oncology
Oncology
2015English

Neoadjuvant Chemoradiotherapy in Rectal Cancer

Memo - Magazine of European Medical Oncology
OncologyHematology
2020English

Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy